• 名称：CB 300919
• 简介：CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft
• CASNO：289715-28-2
• 分子式：C32H34ClN7O2
• 分子量：584.11
• SMILES：CN1CCN(CC1)CC2=NC3=CC(=C(C=C3C(=O)N2C)CN(CC#C)C4=CC=C(C=C4)C(=O)NCC5=CN=CC=C5)Cl
• 保持条件：at -20°C 3 years Powder
• 同名：CB300919, CB-300919
• 纯度：>98%